Onconomics PlusRGCC provides information about the effect of specific anti-cancer drugs, targeted therapies and natural treatments on the cancer cells in an individual patient.
During the test, a sample of blood or tissue is analysed to test how effective specific therapies and treatments are at suppressing cancer.
Together, the results of the extensive tests provide scientists and clinicians with a comprehensive breakdown of the most suitable and successful treatments for cancer. The results can be used by clinicians to design personalised and targeted cancer therapies with the highest chances of success.
Test details
Sample type
Blood or tissue for Central Nervous System Primary Tumors
Analysis period
Approx. 7 days
Cancer type
Applicable for all cancer types
Final results
7-10 days after sample delivery
Sample size
15-25 ml peripheral whole blood. Tissue sample: Minimum 400mg.
Price*
2050 €
* The prices of the tests may be an issue of local additional taxes and value added taxes which are dependent of each country’s legislation. The prices may vary in areas that are under the jurisdiction of a distributor. These prices are for the tests only, and they do not include in-office fees such as consultation, blood draws, etc.
* RGCC is not liable for any third-party comments or claims regarding our products. For accurate and up-to-date information about our offerings, please refer to our official website: rgcc-international.com
